Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Chen-Walden Hana, Director. Director active across 1 company, notably Bioxytran, INC. Cumulatively, 3 disclosures have been recorded. History available since 29 November 2021. The latest transaction was disclosed on 18 April 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Hana Chen-Walden is a Board Member at Bioxytran, Inc. She contributes to the governance of the company by participating in strategic decision-making and ensuring compliance with regulations. Her expertise is valuable for the company.